Title
Amyloid precursor protein processing in human neurons with an allelic series of the PSEN1 intron 4 deletion mutation and total presenilin-1 knockout
Date Issued
01 January 2019
Access level
open access
Resource Type
journal article
Author(s)
Arber C.
Toombs J.
Pocock J.M.
Ryan N.S.
Fox N.C.
Zetterberg H.
Hardy J.
Wray S.
UCL Queen Square Institute of Neurology
Publisher(s)
Oxford University Press
Abstract
Mutations in presenilin-1 (PSEN1), encoding the catalytic subunit of the amyloid precursor protein-processing enzyme γ-secretase, cause familial Alzheimer's disease. However, the mechanism of disease is yet to be fully understood and it remains contentious whether mutations exert their effects predominantly through gain or loss of function. To address this question, we generated an isogenic allelic series for the PSEN1 mutation intron 4 deletion; represented by control, heterozygous and homozygous mutant induced pluripotent stem cells in addition to a presenilin-1 knockout line. Induced pluripotent stem cell-derived cortical neurons reveal reduced, yet detectable amyloid-beta levels in the presenilin-1 knockout line, and a mutant gene dosage-dependent defect in amyloid precursor protein processing in PSEN1 intron 4 deletion lines, consistent with reduced processivity of γ-secretase. The different effects of presenilin-1 knockout and the PSEN1 intron 4 deletion mutation on amyloid precursor protein-C99 fragment accumulation, nicastrin maturation and amyloid-beta peptide generation support distinct consequences of familial Alzheimer's disease-associated mutations and knockout of presenilin-1 on the function of γ-secretase.
Volume
1
Issue
1
Language
English
Subjects
Scopus EID
2-s2.0-85079168859
Source
Brain Communications
ISSN of the container
26321297
Sponsor(s)
This research was supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre and the Leonard Wolfson Experimental Neurology Centre. The work was also partly supported by the UK Dementia Research Institute at UCL. C.A. is supported by a fellowship from the Alzheimer's Society (AS-JF-18-008) and S.W. is supported by an Alzheimer's Research UK Senior Research Fellowship (ARUK-SRF2016B-2). N.S.R. is supported by a University of London Chadburn Academic Clinical Lectureship in Medicine. N.C.F. acknowledges the support of the UK Dementia Research Institute at UCL. This work was also supported by the UK Medical Research Council funding to the MRC Dementia Platform UK (MR/M02492X/1) and Medical Research Council core funding to the High-Content Biology Platform at the MRC-UCL LMCB university unit (MC-U12266B).
Sources of information:
Directorio de Producción Científica
Scopus